Thomas Knittel

This profile gathers the share dealings of Thomas Knittel across 2 companies, led by Index Pharmaceuticals Holding and InDex Pharmaceuticals Holding AB. The record holds 7 filings, for trades running from 19 January 2017 to 12 July 2017.

The open-market side counts 3 purchases for €5,489 alongside 4 sales for €8,738. Taken together, the sales exceed the purchases by €3,249. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

In size, the median ticket on the buying side is €1,503. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 12 July 2017: an open-market sale of €1,134, in Index Pharmaceuticals Holding. The last purchase on record was published on 12 July 2017, which is 3,405 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, MAR article 19 gives managers three business days to notify a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.